Literature DB >> 16755381

Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies.

M Fasano1, B Bergamasco, L Lopiano.   

Abstract

Human mesencephalic neuromelanin (NM) is characterized by an irregular, undefined structure, making its characterization by usual physico-chemical methodologies quite difficult. NM isolated from controls and from Parkinson's Disease (PD) patients was compared by high-resolution solid-state nuclear magnetic resonance (NMR). The pigment from PD patients appeared to be mainly composed of highly cross-linked, protease-resistant lipo-proteic material, with disappearance of melanin NMR resonances, suggesting melanin breakout due to oxidative stress conditions. Moreover, alpha-synuclein was detected in NM of PD patients and controls after cleavage of the melanin backbone under solubilizing conditions. NM stores iron ions as oxyhydroxide iron clusters containing thousands of iron atoms. Electron Paramagnetic Resonance (EPR) investigations and magnetic susceptibility measurements confirmed the occurrence of magnetic coupling among iron atoms, whereas in synthetic melanin the occurrence of isolated Fe(3+) ions was evident. NM from PD patients showed a lower total magnetization, possibly suggesting a progressive Fe migration from its storage environment (i.e., NM) to the cytosol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16755381     DOI: 10.1007/s00702-005-0448-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  18 in total

1.  Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation.

Authors:  L Lopiano; M Fasano; S Giraudo; G Digilio; S H Koenig; E Torre; B Bergamasco; S Aime
Journal:  Neurochem Int       Date:  2000-10       Impact factor: 3.921

2.  NMR studies of melanins: characterization of a soluble melanin free acid from Sepia ink.

Authors:  S Aime; M Fasano; E Terreno; C J Groombridge
Journal:  Pigment Cell Res       Date:  1991-12

3.  Magnetic investigations of human mesencephalic neuromelanin.

Authors:  F Bolzoni; S Giraudo; L Lopiano; B Bergamasco; M Fasano; P R Crippa
Journal:  Biochim Biophys Acta       Date:  2002-03-16

4.  EPR investigations of the iron domain in neuromelanin.

Authors:  S Aime; B Bergamasco; D Biglino; G Digilio; M Fasano; E Giamello; L Lopiano
Journal:  Biochim Biophys Acta       Date:  1997-07-10

5.  Isolation and 13C-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease.

Authors:  S Aime; B Bergamasco; M Casu; G Digilio; M Fasano; S Giraudo; L Lopiano
Journal:  Mov Disord       Date:  2000-09       Impact factor: 10.338

6.  Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.

Authors:  K L Double; L Zecca; P Costi; M Mauer; C Griesinger; S Ito; D Ben-Shachar; G Bringmann; R G Fariello; P Riederer; M Gerlach
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

7.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

Review 8.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

Review 9.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

10.  Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes.

Authors:  L Zecca; M Gallorini; V Schünemann; A X Trautwein; M Gerlach; P Riederer; P Vezzoni; D Tampellini
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

View more
  10 in total

Review 1.  γ-Glutamylamines and neurodegenerative diseases.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Amino Acids       Date:  2012-03-10       Impact factor: 3.520

2.  Early post-natal iron administration induces astroglial response in the brain of adult and aged rats.

Authors:  Liana Lisboa Fernandez; Maria Noêmia Martins de Lima; Felipe Scalco; Gustavo Vedana; Clívia Miwa; Arlete Hilbig; Mônica Vianna; Nadja Schröder
Journal:  Neurotox Res       Date:  2010-12-17       Impact factor: 3.911

3.  Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach.

Authors:  Florian Tribl; Esther Asan; Thomas Arzberger; Thomas Tatschner; Elmar Langenfeld; Helmut E Meyer; Gerhard Bringmann; Peter Riederer; Manfred Gerlach; Katrin Marcus
Journal:  Mol Cell Proteomics       Date:  2009-03-24       Impact factor: 5.911

4.  EPR Studies of DOPA-Melanin Complexes with Netilmicin and Cu(II) at Temperatures in the Range of 105-300 K.

Authors:  Magdalena Zdybel; Barbara Pilawa; Ewa Buszman; Dorota Wrześniok; Ryszard Krzyminiewski; Zdzisław Kruczyński
Journal:  Appl Magn Reson       Date:  2012-05-13       Impact factor: 0.831

Review 5.  The role of oxidative stress in Parkinson's disease.

Authors:  Vera Dias; Eunsung Junn; M Maral Mouradian
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

6.  Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis.

Authors:  Emanuele Ferrari; Mireille Engelen; Enrico Monzani; Michela Sturini; Stefania Girotto; Luigi Bubacco; Luigi Zecca; Luigi Casella
Journal:  J Biol Inorg Chem       Date:  2012-10-31       Impact factor: 3.358

Review 7.  Melanins as Sustainable Resources for Advanced Biotechnological Applications.

Authors:  Hanaa A Galeb; Emma L Wilkinson; Alison F Stowell; Hungyen Lin; Samuel T Murphy; Pierre L Martin-Hirsch; Richard L Mort; Adam M Taylor; John G Hardy
Journal:  Glob Chall       Date:  2020-11-25

8.  Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging.

Authors:  Dmitrii E Korzhevskii; Olga V Kirik; Valeriia V Guselnikova; Darya L Tsyba; Elena A Fedorova; Igor P Grigorev
Journal:  Eur J Histochem       Date:  2021-09-01       Impact factor: 3.188

9.  Dopamine oxidation and autophagy.

Authors:  Patricia Muñoz; Sandro Huenchuguala; Irmgard Paris; Juan Segura-Aguilar
Journal:  Parkinsons Dis       Date:  2012-08-26

Review 10.  Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation.

Authors:  Sandro Percário; Aline da Silva Barbosa; Everton Luiz Pompeu Varela; Antônio Rafael Quadros Gomes; Michelli Erica Souza Ferreira; Thayana de Nazaré Araújo Moreira; Maria Fani Dolabela
Journal:  Oxid Med Cell Longev       Date:  2020-10-12       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.